Advisory Services Network’s Genetic Technologies Ltd. GENE Stock Holding History

Advisory Services Network’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20	Closed	–	–	3292
2019 Q3	$0	Buy	20 +15	+300%	+$167	﹤0.01%	2856
2019 Q2	$0	Hold	5	–	–	﹤0.01%	2945
2019 Q1	$0	Buy	+5	New	+$83	﹤0.01%	2734

Other funds holding GENE

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Advisory Services Network's GENE Position: Q4 2019 in Review

Advisory Services Network sold out of Genetic Technologies Ltd. (GENE) in Q4 2019, closing a stake of 20 shares.

Advisory Services Network first reported a position in GENE in Q1 2019 and held it in 3 quarters. The position peaked at $0 in Q3 2019. 5 funds tracked by Wall St. Rank hold GENE as of Q4 2019.

Advisory Services Network reported no remaining Genetic Technologies Ltd. position as of Q4 2019 after selling out during the quarter.
Advisory Services Network sold 20 Genetic Technologies Ltd. shares in Q4 2019.
Advisory Services Network first reported a position in Genetic Technologies Ltd. in Q1 2019 and held it in 3 quarters.
Advisory Services Network's Genetic Technologies Ltd. position peaked at $0 in Q3 2019.
5 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2019.

Based on Advisory Services Network's 13F filing for Q4 2019, filed 4 Feb 2020.